Cancer Vaccine Breakthrough
-
{
- All
- News
-
Moderna-Merck Breakthrough Cancer Vaccine Shows Promise In Clinical Trial For Melanoma Treatment
A personalised mRNA cancer vaccine from Moderna and Merck has met key goals in a Phase 3 melanoma trial. The treatment is designed around mutations unique to each patient's tumour, potentially opening a new chapter in personalised cancer care
-
Russia's Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials
Russian Mrna Vaccine Cancer: Enteromix, has achieved 100% efficacy and safety in early clinical trials targeting colorectal cancer. Developed using COVID-19 vaccine technology, it's now awaiting regulatory approval.
-
Russia's Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials
Russian Mrna Vaccine Cancer: Enteromix, has achieved 100% efficacy and safety in early clinical trials targeting colorectal cancer. Developed using COVID-19 vaccine technology, it's now awaiting regulatory approval.
-
Moderna-Merck Breakthrough Cancer Vaccine Shows Promise In Clinical Trial For Melanoma Treatment
A personalised mRNA cancer vaccine from Moderna and Merck has met key goals in a Phase 3 melanoma trial. The treatment is designed around mutations unique to each patient's tumour, potentially opening a new chapter in personalised cancer care
-
Russia's Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials
Russian Mrna Vaccine Cancer: Enteromix, has achieved 100% efficacy and safety in early clinical trials targeting colorectal cancer. Developed using COVID-19 vaccine technology, it's now awaiting regulatory approval.
-
Russia's Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials
Russian Mrna Vaccine Cancer: Enteromix, has achieved 100% efficacy and safety in early clinical trials targeting colorectal cancer. Developed using COVID-19 vaccine technology, it's now awaiting regulatory approval.
